Browsing: drug

Medicare’s new power to negotiate drug prices will lead to an estimated $6 billion in savings for the federal government…

Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a…

(Reuters) – U.S. drugmaker Eli Lilly (NYSE:) expects its blockbuster weight-loss drug to officially come out of shortage in the…

By Amina Niasse and Bhanvi Satija (Reuters) -U.S. pharmaceutical industry middlemen defended their role in the healthcare system during a…

By Patrick Wingrove and Bhanvi Satija (Reuters) -Johnson & Johnson beat estimates for second-quarter profit and revenue on Wednesday, driven…

By Jody Godoy and Mariam Sunny (Reuters) -The U.S. Federal Trade Commission is planning to sue UnitedHealth (NYSE:), Cigna (NYSE:)…

LONDON (Reuters) – Shares in Novo Nordisk (NYSE:), maker of the wildly popular obesity drug Wegovy, were down 1.9% on…

By Ahmed Aboulenein and Jody Godoy WASHINGTON (Reuters) – The consolidation of pharmacies and health insurance companies through years of…

As the use of popular weight loss and diabetes drugs like Wegovy and Ozempic skyrockets, consumer brands are scrambling to adapt.…

By Andrew Silver SHANGHAI (Reuters) – Novo Nordisk (NYSE:)’s hugely popular weight-loss drug Wegovy has been approved in China, it…